工程HSV-1用于瘤治疗:从分子进入机制到重定位策略
Yufang Zou1, Juan Tao1, Yingzheng Gao1
1Key Laboratory of the Second Affiliated Hospital of Kunming Medical College, Kunming, Yunnan 650101, China.
Genes & diseases
|December 17, 2025
概括
瘤性简单性疹病毒1型 (HSV-1) 提供了一个有前途的癌症免疫疗法. 工程HSV-1葡萄糖蛋白改善瘤向和治疗癌症晚期治疗的疗效.
科学领域:
- 瘤治疗性病毒疗法
- 癌症免疫疗法癌症免疫疗法
- 病毒载体工程是病毒载体工程.
背景情况:
- 瘤病毒 (OVs) 选择性地破坏癌细胞.
- 简单疹病毒1型 (HSV-1) 由于其安全性和遗传适应性,是一个强大的OV候选者.
- 现有的HSV-1 OVs (oHSV-1) 是有前途的,但可以通过安全驱动的减弱来限制.
研究的目的:
- 审查HSV-1输入的分子机制.
- 检查oHSV-1针对瘤特定向的工程进步.
- 讨论基于HSV-1的结肠病治疗方法的未来方向.
主要方法:
- 探索HSV-1糖蛋白在细胞进入中的功能.
- 对oHSV-1重定位的基因工程策略的分析.
- 审查oHSV-1开发的临床进展和挑战.
主要成果:
- 通过HSV-1糖蛋白 (gD,gH/gL,gB) 介导病毒进入细胞.
- 重定位这些葡萄糖蛋白可以提高瘤的特异性和疗效.
- 已批准的oHSV-1疗法显示出临床潜力.
结论:
- 修改HSV-1葡萄糖蛋白是改善结性病毒治疗的关键.
- 工程HSV-1载体为癌症治疗提供了增强的特异性和有效性.
- 对HSV-1进入机制的进一步研究将推动未来的治疗开发.
相关概念视频
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Microorganisms in Medicine and Therapeutics
914
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
914
Cancer Vaccines
929
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
929
Cytotoxic T Cells-mediated Immune Response
6.4K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.4K


